摘要:
A method comprises introducing a fluid composition into one or more electrically insulating emitters, and applying voltage to the fluid to cause ejection of the solvent from the fluid after it exits the emitter. The fluid composition comprises first material having a dielectric constant greater than ˜25 and polymer mixed into liquid solvent having a dielectric constant less than ˜15, or polymer mixed into solvent having a dielectric constant greater than ˜8. Voltage can be applied to the fluid composition via a conductive electrode immersed in the fluid, or positioned outside and adjacent to the emitters. Conductivity of the fluid composition can be less than ˜100 μS/cm. A composition of matter comprises nanofibers formed by the method.
摘要:
A method of forming an absorbent product, including providing a base layer and co-forming a plurality of fibers and an absorbent material and then depositing the fibers and absorbent material onto the base layer. At least some of the fibers serve as a matrix for supporting the absorbent material, and the fibers and absorbent material generally cooperate so as to form an absorbent core of the absorbent product.
摘要:
A method of reducing, treating or preventing drug-mediated respiratory depression, muscle rigidity, or nausea/vomiting in an animal, incident to the administration to said animal of a mixed delta/mu opioid agonist or a respiratory depression-mediating drug, comprising administering to the animal receiving said drug an effective amount of a delta receptor agonist compound.
摘要:
The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
摘要:
The present invention relates to, inter alia, methods and compositions for reducing, treating or preventing respiratory depression in an animal, using a compound of the formula: ##STR1## wherein: Ar, G, Z, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined in specification, or a pharmaceutically acceptable ester or salt thereof.
摘要:
A training cage for throwing practice, comprises a frame having a height, width and depth. The training cage also comprises a strike zone indicator that defines the boundaries of a strike zone and a pitch locator. The pitch locator is configured such that when the pitch locator is in cooperation with the strike zone indicator, the strike zone is defined by at least one strike area pass through that defines an area that allows a ball thrown within the strike zone to pass through the strike zone indicator and at least one strike area barricade that defines an area that obstructs the ball thrown within the strike zone from passing through the strike zone indicator. Moreover, the pitching cage comprises a target having a target surface that is suspended in a second designated position located behind the strike zone indicator.
摘要:
A training cage for throwing practice, comprises a frame having a height, width and depth. The training cage also comprises a strike zone indicator that defines the boundaries of a strike zone and a pitch locator. The pitch locator is configured such that when the pitch locator is in cooperation with the strike zone indicator, the strike zone is defined by at least one strike area pass through that defines an area that allows a ball thrown within the strike zone to pass through the strike zone indicator and at least one strike area barricade that defines an area that obstructs the ball thrown within the strike zone from passing through the strike zone indicator. Moreover, the pitching cage comprises a target having a target surface that is suspended in a second designated position located behind the strike zone indicator.
摘要:
A variety of small molecule, guanidine-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases when administered to subjects. The compounds have the structures VA, VB, VIIA and VIIB where the values of the variables are defined herein.
摘要:
A method of reducing, treating or preventing drug-mediated respiratory depression in an animal, incident to the administration to said animal of a respiratory depression-mediating drug, comprising administering to the animal receiving said drug an effective amount of a .delta. receptor agonist compound.
摘要:
Diarylmethyl piperazine compounds having utility as exogenous receptor combinant species for binding with receptors such as delta, mu, sigma, and/or kappa receptors are disclosed. Compounds of the invention may be employed as conjugates in agonist/antagonist pairs for transductional monitoring and assays of neurotransmitter function, and also variously exhibit therapeutic utility, including mediating analgesia, and possessing utility for the treatment of diarrhea, urinary incontinence, mental illness, drug and alcohol addiction/overdose, lung edema, depression, asthma, emphysema, cough, and apnea, respiratory depression, cognitive disorders, emesis and gastrointestinal disorders.